
Ankeet Bhatt, MD, MBA, ScM, explains how prediction markets could threaten clinical trial integrity by undermining participant retention and trust.
Panelists discuss the key considerations for properly coding chronic kidney disease (CKD) diagnoses, with a particular focus on the nuances involved in coding for early-stage CKD.






